Marpai, Inc.
MRAI- Exchange
- OTC
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001844392
No open-market purchases or sales by Marpai, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Marpai, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 9 | 0 | −9 |
| Shares | 222.5K | 0 | −222.5K (−100.0%) |
| Value | $542.8K | $0 | −$542.8K (−100.0%) |
New holders (0)
Institutions that held Marpai, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
None.
Sold out (9)
Institutions that held Marpai, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Vanguard Group Inc | 96,992 | $236.7K |
| Geode Capital Management, LLC | 45,194 | $110.3K |
| Northern Trust Corp | 22,398 | $54.7K |
| State Street Corp | 20,507 | $50.0K |
| Jane Street Group, LLC | 13,537 | $33.0K |
| Omers Administration Corp | 11,500 | $28.1K |
| UBS Group AG | 9,578 | $23.4K |
| Tower Research Capital LLC (TRC) | 2,724 | $6.65K |
| Wells Fargo & Company | 40 | $98 |